Masatoshi Ogawa

460 total citations
29 papers, 333 citations indexed

About

Masatoshi Ogawa is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Masatoshi Ogawa has authored 29 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Masatoshi Ogawa's work include Antibiotic Resistance in Bacteria (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Probiotics and Fermented Foods (3 papers). Masatoshi Ogawa is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Probiotics and Fermented Foods (3 papers). Masatoshi Ogawa collaborates with scholars based in Japan and United States. Masatoshi Ogawa's co-authors include Ken‐ichi Tomochika, H. Ohmori, Hiromi Kumon, Sachiko Gotô, Akiyoshi Tsuji, Yasuko Kaneko, Harutoshi Ogai, Jiro Kasahara, Shōgo Kuwahara and Satoshi Goto and has published in prestigious journals such as Science, Biochemical and Biophysical Research Communications and Toxicology and Applied Pharmacology.

In The Last Decade

Masatoshi Ogawa

24 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masatoshi Ogawa Japan 7 159 43 37 36 36 29 333
R W Hawkinson United States 11 87 0.5× 20 0.5× 29 0.8× 35 1.0× 24 0.7× 18 880
A Morán Ireland 5 82 0.5× 29 0.7× 20 0.5× 11 0.3× 76 2.1× 11 388
Senka Džidić Croatia 9 194 1.2× 9 0.2× 38 1.0× 98 2.7× 34 0.9× 15 542
J. Koo Canada 12 201 1.3× 37 0.9× 46 1.2× 24 0.7× 12 0.3× 19 600
A. Maes Belgium 11 50 0.3× 30 0.7× 56 1.5× 12 0.3× 19 0.5× 17 285
Truc Thanh Luong South Korea 12 214 1.3× 30 0.7× 10 0.3× 15 0.4× 42 1.2× 19 401
Haisi Dong China 11 207 1.3× 16 0.4× 17 0.5× 30 0.8× 28 0.8× 28 313
Nahed Mohamed Egypt 11 97 0.6× 20 0.5× 22 0.6× 44 1.2× 21 0.6× 26 387
Huijuan Cheng China 11 120 0.8× 50 1.2× 10 0.3× 28 0.8× 27 0.8× 30 333
Nizar H. Saeedi Iran 14 259 1.6× 11 0.3× 23 0.6× 68 1.9× 25 0.7× 35 571

Countries citing papers authored by Masatoshi Ogawa

Since Specialization
Citations

This map shows the geographic impact of Masatoshi Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Ogawa more than expected).

Fields of papers citing papers by Masatoshi Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masatoshi Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Ogawa. The network helps show where Masatoshi Ogawa may publish in the future.

Co-authorship network of co-authors of Masatoshi Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masatoshi Ogawa. A scholar is included among the top collaborators of Masatoshi Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masatoshi Ogawa. Masatoshi Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sumi, Daigo, et al.. (2020). Arsenite suppresses IL-2-dependent tumoricidal activities of natural killer cells. Toxicology and Applied Pharmacology. 412. 115353–115353. 3 indexed citations
2.
Ogawa, Masatoshi, et al.. (2019). Video-based assessments of the hind limb stepping in a mouse model of hemi-parkinsonism. Neuroscience Research. 154. 56–59. 4 indexed citations
3.
Ogawa, Masatoshi, et al.. (2019). Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism. Frontiers in Neurology. 10. 1258–1258. 7 indexed citations
4.
Zhou, Yu, et al.. (2018). c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism. Frontiers in Pharmacology. 9. 1311–1311. 4 indexed citations
5.
Taniguchi, Kazuya, et al.. (2003). Driving circuit for single-pulse soft-switching PFC converter. 3. 1232–1237.
6.
Yokota, Takeshi, et al.. (1996). Role of Bacterial Biofilms in the Chemotherapy of Cholangitis with Brown Pigment Stones. Chemotherapy. 42(5). 363–373. 3 indexed citations
7.
Kumon, Hiromi, et al.. (1994). A Sandwich Cup Method for the Penetration Assay of Antimicrobial Agents through Pseudomonas Exopolysaccharides. Microbiology and Immunology. 38(8). 615–619. 96 indexed citations
8.
Shiromizu, Kenji, Masatoshi Ogawa, Hiroyuki Kamata, Keigo Tominaga, & Yasuo Koyama. (1990). long-term Mass Screening in Uterine Cervical Carcinoma Eradication Strategy. Japanese Journal of Clinical Oncology. 20(2). 134–138. 3 indexed citations
9.
Shiromizu, Kenji, et al.. (1989). Reconstruction of Sigmoid Vagina and Conduit in Total Pelvic Exenteration for Recurrent Cervical Carcinoma. Japanese Journal of Clinical Oncology. 19(2). 170–2. 2 indexed citations
10.
Gotô, Sachiko, Masatoshi Ogawa, Yasuko Kaneko, & Shōgo Kuwahara. (1988). IN VITRO AND IN VIVO ANTIBACTERIAL ACTIVITIES OF CS-807, A NEW ORAL CEPHALOSPORIN. Chemotherapy. 36(1). 43–61. 1 indexed citations
11.
Ogawa, Masatoshi, et al.. (1988). Study of the Pathogenecity of Enterococcus faecalis-Experimental Mice Mixed Infection with E. faecalis and Other Organisms. Kansenshogaku zasshi. 62(3). 217–225. 1 indexed citations
12.
Gotô, Sachiko, et al.. (1987). Bacteriological evaluation of a new oxacephem antibiotic, 6315-s (flomoxef). Chemotherapy. 35. 1–21. 2 indexed citations
13.
Ogawa, Masatoshi, Shuichi Miyazaki, & Sachiko Gotô. (1986). Influence of dose schedule on efficacies of antibiotic combinations in Pseudomonas aeruginosa infection in mice.. 34(3). 232–239.
14.
Miyazaki, Shuichi, Tetsuo Ishii, Akiyoshi Tsuji, et al.. (1986). Pathogenic factors in mixed infection due to Bacteroides fragilis and other species of bacteria in mice.. Nippon Saikingaku Zasshi. 41(3). 611–617. 1 indexed citations
15.
Gotô, Sachiko, et al.. (1986). ANTIBACTERIAL ACTIVITY OF HBK A NEW DERIVATIVE OF DIBEKACIN. 34(1). 11–32. 1 indexed citations
16.
Gotô, Sachiko, Masatoshi Ogawa, Yasuko Kaneko, et al.. (1985). Bacteriological studies on sultamicillin. Chemotherapy. 33(1). 37–53.
17.
Gotô, Sachiko, Hiroshi Sakamoto, Masatoshi Ogawa, Akiyoshi Tsuji, & Shōgo Kuwahara. (1982). Bactericidal Activity of Cefazolin, Cefoxitin, and Cefmetazole against <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>. Chemotherapy. 28(1). 18–25. 10 indexed citations
18.
Tsuji, Akiyoshi, et al.. (1979). Bactericidal Activities of Various Disinfectants in Responce to the Concentration, Period of Exposure and Addition of Blood Serum. Kansenshogaku zasshi. 53(6). 292–303. 1 indexed citations
19.
Gotô, Sachiko, Masatoshi Ogawa, Yasuko Kaneko, Akiyoshi Tsuji, & Shōgo Kuwahara. (1978). LABORATORY EVALUATION OF CEFOXITIN, A BROAD SPECTRUM ANTIBIOTIC OF THE CEPHAMYCIN GROUP AND CEPHALOSPORINS. 26(1). 26–40. 1 indexed citations
20.
Ogawa, Masatoshi, et al.. (1961). Genetical and Geographic Studies on Isoniazid Inactivation. Science. 134(3489). 1530–1531. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026